The Meta-analysis Group was established within the MRC Cancer
Trials Office in Cambridge in 1988, with one full-time member of
staff. The Group has expanded to enable it to work on a range of
systematic reviews, individual participant data (IPD) meta-analyses
and methodological research projects and currently has 5 members of
staff. This also allows the Group to provide training and support
on systematic reviews and meta-analysis, both internally and
externally.
Most of the Group’s ongoing and published systematic reviews and
meta-analyses are in the cancer field (e.g. bladder, brain,
gynaecological, lung and soft tissue cancer). However, since
becoming as part of the MRC Clinical Trials Unit in 1999, it has
conducted these projects in other diseases and conditions.
Dr Jayne Tierney is the Group Head.
